Search hospitals
>
Ohio
>
Franklin
Atrium Medical Center-Middletown Regional Hospital
Claim this profile
Franklin, Ohio 45005
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
366 reported clinical trials
4 medical researchers
Summary
Atrium Medical Center-Middletown Regional Hospital is a medical facility located in Franklin, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Atrium Medical Center-Middletown Regional Hospital is involved with conducting 366 clinical trials across 436 conditions. There are 4 research doctors associated with this hospital, such as Howard M. Gross, Tarek M. Sabagh, Michael Guy, MD, and Jhansi L. Koduri.
Area of expertise
Breast Cancer
Atrium Medical Center-Middletown Regional Hospital has run 71 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Atrium Medical Center-Middletown Regional Hospital has run 56 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Howard M. Gross
Kettering Medical Center
6 years of reported clinical research
Tarek M. Sabagh
Miami Valley Hospital South
2 years of reported clinical research
Michael Guy, MD
Miami Valley Hospital South
2 years of reported clinical research
Jhansi L. Koduri
Miami Valley Hospital South
2 years of reported clinical research
Clinical Trials running at Atrium Medical Center-Middletown Regional Hospital
Lung Cancer
Bladder Cancer
Breast Cancer
Cancer
Esophageal cancer
Breast cancer
Kidney Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Cutaneous Melanoma
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Atrium Medical Center-Middletown Regional Hospital?
Atrium Medical Center-Middletown Regional Hospital is a medical facility located in Franklin, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Atrium Medical Center-Middletown Regional Hospital is involved with conducting 366 clinical trials across 436 conditions. There are 4 research doctors associated with this hospital, such as Howard M. Gross, Tarek M. Sabagh, Michael Guy, MD, and Jhansi L. Koduri.
Where is Atrium Medical Center-Middletown Regional Hospital located?
**Atrium Medical Center-Middletown Regional Hospital** - **Address:** 1 Medical Center Drive, Middletown, OH 45005 - **Parking:** Use the south entrance off Market Avenue, which becomes Medical Center Drive. Parking lots A and B are near the main entrance, while lots C and D serve the Professional Building.
Who should I call to ask about financial aid or insurance network?
**Atrium Medical Center-Middletown Regional Hospital Contact Information** **Financial Assistance:** - **Phone:** 704-512-7171 or 844-440-6536 - **Address:** Atrium Health Business Office, ATTN: Coverage Assistance Services, PO Box 32861, Charlotte, NC 28232-2861 **Insurance:** - **Phone:** (513) 974-2111 (Main operator), (513) 974-4530 (Inquiries about current patients), (800) 338-4057 (Toll-free)
What insurance does Atrium Medical Center-Middletown Regional Hospital accept?
Atrium Medical Center-Middletown Regional Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Anthem/Blue Cross Blue Shield, Cigna, Humana, Medical Mutual, Molina, United Behavioral/Optum Health, United HealthCare, and WellCare Medicare (Allwell). Coverage extends to Medicare, Medicaid, various commercial insurance networks, Medicare HMO/PPO networks, Medicaid managed care plans, and health insurance marketplace/exchange plans. It is advised to verify with your insurance provider if Premier Health is within your plan's network.
What awards or recognition has Atrium Medical Center-Middletown Regional Hospital received?
Atrium Medical Center-Middletown Regional Hospital, located in Franklin, Ohio, is renowned for its excellence in three adult procedures and conditions. It proudly holds the designation of a Primary Stroke Center, certified by The Joint Commission. Furthermore, the hospital has earned the Geriatric Emergency Department Accreditation (GEDA) from the American College of Emergency Physicians (ACEP).
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.